Multi-organ Gene Therapy for Bloom Syndrome

Awardee: Amy Wagers

Institution: Harvard University

Awarded: $100,000

Funding Period: September 1, 2022 - August 31, 2024

Previous
Previous

Development of Normal and Tumor Organoids from Bloom Syndrome to Evaluate Responses to Pharmacological and Genetic Perturbations

Next
Next

Molecular mechanisms of EPHB4 pathogenesis – towards new treatment development for lymphatic anomalies